PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β

The development of targeted tyrosine kinase inhibitors (TKIs) has succeeded in altering the course of chronic myeloid leukemia (CML). However, a number of patients have failed to respond or experienced disease relapse following TKI treatment. Proviral integration site for moloney murine leukemia vir...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Med Rep
Main Authors: Fan, Rui-Fang, Lu, Ying, Fang, Zhi-Gang, Guo, Xiao-Yan, Chen, Yu-Xin, Xu, Yi-Chuan, Lei, Ya-Mei, Liu, Ke-Fang, Lin, Dong-Jun, Liu, Ling-Ling, Liu, Xiang-Fu
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5647015/
https://ncbi.nlm.nih.gov/pubmed/28849186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.7215
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados